Skip to main content
. Author manuscript; available in PMC: 2014 Jul 1.
Published in final edited form as: Mol Cancer Ther. 2013 May 8;12(7):1245–1254. doi: 10.1158/1535-7163.MCT-12-1150

Table 2.

FGFR3 mutation analysis of tumor samples and urothelial carcinoma cell lines.

Tumor samples
Low grade High grade Total
Non-invasive 28/50 = 56% 2/18 = 11% 30/68 = 46%
Invasive 4/7 = 57% 10/95 = 11% 14/102 = 22%
Total 32/57 = 56% 12/113 = 11% 44/170 = 26%

Exon 7 mutation: 31 (70%) Exon 10 mutation: 13 (30%)

Exon Nucleotide position /
base change
Codon / change in
amino acid
N
7 746 C>G S249C 31
10 1114 G>T G372C 4
10 1117 A>T S373C 1
10 1124 A>G Y375C 7
10 1156 T>C F386L 1
Cell lines
Cell line Exon 7 Exon 10 Cell line Exon 7 Exon 10
253J-P wt wt UM-UC7 wt wt
253J-BV wt wt UM-UC10 wt wt
RT4 v6 wt wt UM-UC11 wt wt
RT112 wt wt UM-UC12 wt wt
T24 wt wt UM-UC13 wt wt
UM-UC1 wt wt UM-UC14 S249C wt
UM-UC3 wt wt UM-UC15 S249C Y375C
UM-UC4 wt wt UM-UC16 S249C wt
UM-UC5 wt wt UM-UC17 S249C wt
UM-UC6 R248C wt